WW International, Inc. (WW)
| Market Cap | 97.97M |
| Revenue (ttm) | 710.64M |
| Net Income (ttm) | 1.06B |
| Shares Out | 10.00M |
| EPS (ttm) | 23.82 |
| PE Ratio | 0.41 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 307,463 |
| Open | 10.31 |
| Previous Close | 10.51 |
| Day's Range | 9.77 - 10.50 |
| 52-Week Range | 8.91 - 46.95 |
| Beta | 1.06 |
| Analysts | Buy |
| Price Target | 45.17 (+360.92%) |
| Earnings Date | May 7, 2026 |
About WW
WW International, Inc. provides weight management products and services in the United States, Germany, Canada, and internationally. It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, as well as for people taking GLP-1 medications or living with diabetes, as well as offers guidance and medication access for women reaching perimenopause and menopause. The company also provides Core, a digital subscription product for weight loss and weight management; Core+ tier, a subscription for... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for WW stock is "Buy." The 12-month stock price target is $45.17, which is an increase of 360.92% from the latest price.
News
Weight Watchers Announces Actions to Utilize Up to $40 million to Pay Down Debt
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that it in...
Weight Watchers Schedules First Quarter 2026 Earnings Conference Call
NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”) will release its results for the first quarter 2026 ended March 31, 2026, before m...
Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that it ha...
Weight Watchers Announces Board Committee Appointments
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced the follow...
Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors
New, Independent Directors Bring Deep Consumer, Digital and Turnaround Expertise to Support Strategic Transformation New, Independent Directors Bring Deep Consumer, Digital and Turnaround Expertise to...
Weight Watchers Announces Leadership Transition and Board Updates
Office of the CEO Established to Oversee Business Operations Board Forms Transition Committee and Commences CEO Search NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW)...
Top 3 Consumer Stocks That Are Preparing To Pump This Quarter
The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies.
Weight Watchers Announces Best in Market Self-Pay Wegovy® Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare®
Through expanded collaboration with Novo Nordisk, eligible Med+ members can now save up to $1,200 per year on Wegovy®, increasing affordable access to FDA-approved GLP-1 treatment leveraging Weight Wa...
WW International Earnings Call Transcript: Q4 2025
Exited Chapter 11, eliminated $1.1B in debt, and beat 2025 revenue and adjusted EBITDA guidance. Clinical subscriber growth is strong, with Med+ and GLP-1 programs driving higher ARPU and member engagement, while behavioral business faces ongoing headwinds.
Weight Watchers Announces Fourth Quarter and Full Year 2025 Results
2025 Total Revenue and Adjusted EBITDA 1,2 above high end of previously provided guidance Total End of Period Subscribers of 2.8 million; End of Period Clinical Subscribers of 130 thousand, up 42% yea...
Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call
NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”) will release its results for the fourth quarter and full year 2025 ended December 3...
Weight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era
The new partnership combines Weight Watchers' scientifically-backed medical and behavioral expertise with PVOLVE's clinically-studied method to support members at every age and stage of life The new p...
WW International Transcript: CJS Securities 26th Annual "New Ideas for the New Year” Investor Conference
The company is integrating GLP-1 medications with behavioral support, leveraging financial restructuring to invest in innovation, and expanding its offerings with targeted programs like menopause support. Strategic partnerships and technology upgrades are driving growth and member engagement.
Weight Watchers Expands Its Integrated GLP-1 Platform with Access to Wegovy® Pill Advancing a New Standard for Long-Term Weight Health
A NovoCare® Recognized Care Provider, Weight Watchers' new Med+ program delivers an integrated GLP-1 care model proven to drive greater weight loss results than medication alone A NovoCare® Recognized...
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss g...
WeightWatchers to sell Novo Nordisk's Wegovy pill after 2026 launch
WeightWatchers' CEO said on Wednesday it plans to sell Novo Nordisk's much-anticipated Wegovy in pill form if it is launched next year in the United States, deepening its tie-up with the Danish obesit...
WW International Earnings Call Transcript: Q3 2025
Q3 saw revenue decline 11% year over year, but clinical revenue grew 35% and clinical subscribers rose 60%. The company is investing in digital transformation, new product launches, and partnerships, while narrowing 2025 guidance to $695–$700 million in revenue and $145–$150 million in adjusted EBITDA.
WeightWatchers Announces Third Quarter 2025 Results
End of Period Subscribers of 3.0 million, including Clinical Subscribers of 124 thousand Total Revenues of $172 million; Clinical Subscription Revenues of $26 million, up 35% year-over-year Net Loss ...
WeightWatchers International shares climb after partnership with Amazon Pharmacy
Shares of WW International rose nearly 6% in premarket trading on Monday after the company announced a new partnership with Amazon to deliver GLP-1 weight-loss drugs and other prescription medications...
WeightWatchers Collaborates With Amazon Pharmacy to Increase Medication Delivery Speed, Convenience and Savings For Members
NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today announced a collaborat...
WeightWatchers Launches RxFlexFund™, a New Employer Model for Expanding GLP-1 Coverage
Provides a Differentiated Cost-Sharing Framework for GLP-1 Medications Paired With Clinical Oversight and Proven Behavior Change Support from WeightWatchers Clinic Provides a Differentiated Cost-Shari...
WeightWatchers for Business Annual Report Shows Breakthrough Weight Loss Results and Health Outcomes
Members See 46% Improvement in Work-Related Quality of Life and 53% Improvement in Overall Quality of Life
Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Programme
Groundbreaking Programme Tackles Weight, Symptoms and Stigma, Redefining Menopause Care for Millions Groundbreaking Programme Tackles Weight, Symptoms and Stigma, Redefining Menopause Care for Million...
Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Program
Groundbreaking Program Tackles Weight, Symptoms and Stigma, Redefining Menopause Care for Millions Groundbreaking Program Tackles Weight, Symptoms and Stigma, Redefining Menopause Care for Millions
WeightWatchers Advances International Growth With Strategic Leadership Appointment
Alejandro Bethlen to Lead WeightWatchers' Next Phase of International Growth and Innovation, Building on More Than 50 Years in Global Markets Alejandro Bethlen to Lead WeightWatchers' Next Phase of In...